Pernix Therapeutics HoldingsStock Price and Value Analysis

Should you buy Pernix Therapeutics Holdings stock? (NasdaqGM:PTX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This company has wild ups and downs.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

PTX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Pernix Therapeutics Holdings's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for PTX
Free Cash Flow trendline for Pernix Therapeutics Holdings

Inside the PTX Numbers

PTX Price
(Pernix Therapeutics Holdings stock price per share)
$2.30
[?] PE Ratio versus Sector 83% higher than other Healthcare stocks
[?] PE Ratio versus Industry 28% higher than other Drug Manufacturers - Other stocks
[?] Cash Yield -4.56%
[?] Free Cash Flow Jitter 1089%
[?] Dividend Yield 0%

Is Pernix Therapeutics Holdings Stock on Sale?

Based on our analysis, we believe that you should not buy Pernix Therapeutics Holdings right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy PTX Stock?

Does Pernix Therapeutics Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.